• GPT Healthcare intimated NSE and BSE about its upcoming Board meeting on May 18, 2026.
• The Board will consider audited financial results for Q4 and FY ended March 31, 2026.
• The Board will also consider recommending a final dividend for FY 2025-26.
• The trading window closure for insiders is extended until May 20, 2026.